How To Improve Blood Sugar Levels And Reverse Diabetes For Good

How to Improve Blood Sugar Levels and Reverse Diabetes For Good

Every 23 seconds another person is diagnosed with diabetes — one the leading causes of death in the United States.
But these people don’t have to suffer. Diabetes is preventable, manageable, and reversible.
What is Diabetes? — A Quick Overview
There are two types of diabetes — type 1 and type 2.
This is an over-simplified chart, but it gives you a good visual of the differences and similarities between the two. Now, let’s dig a little deeper into each type of diabetes.
Type 2 diabetes is characterized by high blood sugar levels and insulin resistance. Insulin resistance happens when blood sugar levels are so consistently high that the cells don’t respond to insulin (a hormone that helps lower blood sugar) like they used to. When the cell aren’t as sensitive to insulin, blood sugar levels raise even more. As a result, insulin levels raise and the cells become more insulin resistant. This vicious cycle is commonly caused by eating too much sugar, not moving enough, and stressing too much.
Conversely, type 1 diabetes is when the body lacks the ability to produce insulin. In some cases, this is happens because the immune system attacks the cells in the pancreas that make insulin. Despite the lack of insulin, type 1 diabetics can still manage their blood sugar levels by taking exogenous insulin.
Although type 1 and type 2 diabetes are caused in completely different ways, they both lead to higher blood sugar levels that will destroy cells throughout the body and cause chronic inflammation. If we can improve blood sugar levels then we can manage and reverse diabetes Continue reading

Rate this article

Total 1 ratings

Top 10 Best Diabetes Insulin Supply and Travel Case

Top 10 Best Diabetes Insulin Supply and Travel Case
Top 10 Best Diabetes Insulin Travel Cases
When you have diabetes, you know how painful it is to travel with the entire insulin supply; there are numerous things at once, and also they are fragile.
So, in that situation, you need to have good quality insulin travel cases to support the whole package you are carrying. There are several different things like test strips, medications, glucose meter and other backup items.
Hence, Top 10 Best Diabetes Insulin Supply and Travel Case.
Insulin:
Insulin is a hormone that is created by the beta cells in the pancreatic islets. It is responsible for regulating the proper metabolism of different components like Carbohydrates, Proteins, and Fats by helping the glucose in getting absorbed in the fat, muscles and liver cells from the blood.
The glucose is further then converted into glycogen or fats, and when it is the liver tissues, it is converted into both the forms.
The excessive production of glucose is controlled by the insulin present in the blood. The insulin circulation also has effects on the manufacture of proteins. Thus if the insulin levels go down in your blood, it has harsh effects on your whole body.
Types of Insulin: There are various types of Insulin’s, but there are three main types of them:
Fast-acting insulin: This insulin is very quickly absorbed into the blood from the fat tissues. This is also helpful when one wants to control or correct sugar levels in the blood while having meals or snack or even when one wants to correct high levels of sugar in the blood.
Inter Continue reading

Diabetes in Elderly Adults

Abstract
Diabetes is common in the elderly population. By the age of 75, approximately 20% of the population are afflicted with this illness. Diabetes in elderly adults is metabolically distinct from diabetes in younger patient populations, and the approach to therapy needs to be different in this age group. Diabetes is associated with substantial morbidity from macro- and microvascular complications. Several lines of evidence suggest that optimal glycemic control and risk factor modification can substantially reduce the risk of complications in elderly patients. In the past, treatment options were limited. However, recent studies have delineated several new and exciting therapeutic opportunities for elderly patients with diabetes.
Decision Editor: John E. Morley, MB, BCh
Epidemiology
Numerous studies have evaluated the incidence and prevalence of type 2 diabetes in the elderly population. The most recent Health and Nutrition Survey, HANES III, suggests that approximately 20% of the population develop diabetes by the age of 75 (Fig. 1) (1). At least half of these patients are unaware they have the disease (2). The prevalence of diabetes is much higher in some ethnic groups, especially Native Americans, Hispanics, blacks, and Micronesians. Because elderly patients with diabetes are living longer and are likely to use increasing amounts of scarce health care resources in the next several decades, diabetes in aged adults may ultimately prove to be the most important epidemic of the 21st century.
There are several lines of evidence to suggest that type 2 diabetes in elderly adu Continue reading

Incidence of type 1 diabetes in China, 2010-13: population based study

Abstract
Objective To estimate the incidence of type 1 diabetes in all age groups in China during 2010-13.
Design Population based, registry study using data from multiple independent sources.
Setting National registration system in all 505 hospitals providing diabetes care, and communities of patients with diabetes in 13 areas across China, covering more than 133 million person years at risk, approximately 10% of the whole population.
Participants 5018 people of all ages with newly diagnosed type 1 diabetes and resident in the study areas from 1 January 2010 to 31 December 2013.
Main outcome measures Incidence of type 1 diabetes per 100 000 person years by age, sex, and study area. Type 1 diabetes was doctor diagnosed and further validated by onsite follow-up. Completeness of case ascertainment was assessed using the capture mark recapture method.
Results 5018 cases of newly diagnosed type 1 diabetes were ascertained: 1239 participants were aged <15 years, 1799 were aged 15-29 years, and 1980 were aged ≥30 years. The proportion of new onset cases in participants aged ≥20 years was 65.3%. The estimated incidence of type 1 diabetes per 100 000 persons years for all ages in China was 1.01 (95% confidence interval 0.18 to 1.84). Incidence per 100 000 persons years by age group was 1.93 (0.83 to 3.03) for 0-14 years, 1.28 (0.45 to 2.11) for 15-29 years, and 0.69 (0.00 to 1.51) for ≥30 years, with a peak in age group 10-14 years. The incidence in under 15s was positively correlated with latitude (r=0.88, P<0.001), although this association was not observed in age groups 15 Continue reading

Type 2 Diabetes: Mastering Injectable Combination Therapies to Individualize & Optimize Outcomes

For clinicians, the treatment of diabetes can be challenging. Because type 2 diabetes is progressive, a key to successful therapy is the need for additional agents over time. It is critical to have the clinical ability to individualize therapy by patient and medication characteristics. With the availability of injectable combination therapies, there are more opportunities than ever to accommodate patient preferences while improving glycemic control while harnessing the extraglycemic benefits of additional agents to open the door for successful management.
As a value added-resource, a specialized toolkit will also be included as a supplement to the webcast. The toolkit will provide for clinicians the latest treatment guidelines and updated reference guide. In addition, the toolkit will provide helpful information and resources for families and caregivers.
Delineate the factors that should be considered when selecting agents to individualize therapy in type 2 diabetes;
Understand current evidence regarding the efficacy, safety, and limitations of the most recently approved classes of agents for patients who require treatment intensification;
Apply evidence- and guideline-based recommendations to individualize combination therapy when treatment intensification is indicated;
Incorporate effective communication techniques and educational tools to improve the patient’s knowledge of type 2 diabetes and treatment.
Faculty:
John (Jack) L. Leahy, MD
Professor of Medicine
Chief of Endocrinology, Diabetes and Metabolism
University of Vermont
Colchester, Vermont
Moderator:
John J. Rus Continue reading